Ubiquitination of the EGF receptor (EGFR) is believed to play a critical role in regulating both its localization and its stability. To elucidate the role of EGFR ubiquitination, tandem mass spectrometry was used to identify six distinct lysine residues within the kinase domain of the EGFR, which can be conjugated to ubiquitin following growth factor stimulation. Substitution of these lysine residues with arginines resulted in a dramatic decrease in overall ubiquitination but preserved normal tyrosine phosphorylation of EGFR. Ubiquitination-deficient EGFR mutants displayed a severe defect in their turnover rates but were internalized at rates comparable to those of wild-type receptors. Finally, quantitative mass spectrometry demonstrated that more than 50% of all EGFR bound ubiquitin was in the form of polyubiquitin chains, primarily linked through Lys63. Taken together, these data provide direct evidence for the role of EGFR ubiquitination in receptor targeting to the lysosome and implicate Lys63-linked polyubiquitin chains in this sorting process.
Introduction
The intensity, duration, and specificity of signal transduction through receptor tyrosine kinases (RTK) are regulated by ligand-mediated endocytosis and postendocytic trafficking of activated receptors. Internalization of activated RTK and subsequent targeting to degradative organelles result in downregulation of RTK activity and function as a negative feedback on downstream signaling processes (Dikic and Giordano, 2003) . Internalized RTK can form signaling complexes in endosomes, which may trigger qualitatively different signals than receptors located at the plasma membrane (Miaczynska et al., 2004; Sorkin and Von Zastrow, 2002) . Despite the important role of endocytosis in the biological activities of RTK, the molecular mechanisms controlling this process remain poorly understood.
Epidermal growth factor (EGF) receptor (EGFR) has been the primary experimental model used to study the mechanisms of endocytosis. Ligand binding to EGFR at the cell surface leads to rapid internalization of ligand-receptor complexes through clathrin-coated pits (Gorden et al., 1978) . When enough activated EGFR accumulates at the cell surface to saturate the clathrin-dependent pathway, the resulting pool of activated receptors is instead internalized through slow, clathrin-independent pathways (Sigismund et al., 2005; Wiley, 1988) . In either case, internalized ligand-receptor complexes are transferred to early endosomes and subsequently recycled back to the plasma membrane (Hopkins et al., 1985; Sorkin et al., 1991) . After each round of internalization, a significant fraction of internalized receptors are sorted from early endosomes to multivesicular bodies (MVBs), where, instead of being recycled, receptors can be targeted to lysosomes for degradation (Miller et al., 1986) .
Ubiquitination of EGFR has been implicated in both ligand-mediated endocytosis and endosomal sorting. Following EGF binding, EGFR is ubiquitinated by the RING domain E3 ubiquitin (Ub) ligase, Cbl (Levkowitz et al., 1998) . The binding of Cbl to EGFR occurs directly via phosphorylated Tyr1045 of EGFR, as well as indirectly through Grb2. Whereas both interaction modes are necessary for efficient ubiquitination of the receptor, binding of Cbl to EGFR through a direct interaction with Tyr1045 is dispensable for clathrin-dependent internalization of EGFR (Huang and Sorkin, 2005; Waterman et al., 2002) .
Ubiquitination refers to the conjugation of Ub to the 3-amino group of a lysine residue within a substrate. Monoubiquitination has previously been shown to be necessary for ligand-mediated endocytosis of the a factor receptor in yeast (Hicke and Dunn, 2003) . Previous reports suggested that EGFR is exclusively modified by monoubiquitin, consistent with the importance of this modification in receptor sorting at the plasma membrane and endosomes (Haglund et al., 2003; Mosesson et al., 2003) . While some substrates are modified only by mono-Ub, poly-Ub chains can form through each of the seven lysine residues within Ub itself (Peng et al., 2003) . Lys48-linked poly-Ub chains are generally believed to target proteins to the proteasome for degradation, while Lys63 linkages have been shown to regulate processes such as DNA repair and kinase activation through proteasome independent mechanisms.
Despite a wide array of experimental approaches, evidence supporting the importance of EGFR ubiquitination in receptor trafficking remains indirect. Although studies utilizing Tyr1045 mutation have shown this residue to play a critical role in EGFR ubiquitination and trafficking (Levkowitz et al., 1999) , its effects can alternatively be attributed to impaired phosphorylation of neighboring serine residues (Oksvold et al., 2003) . Furthermore, a series of endosomal proteins including Hrs and ESCRT complexes I, II, and III, each containing a Ub binding domain(s), are thought to participate in trapping EGFR within internal vesicles of MVBs, although the sequence of protein-protein interactions between ubiquitinated EGFR and ESCRT proteins during this process has not been experimentally elucidated. It is possible to inhibit EGFR degradation by RNAi knockdown of Hrs and ESCRT proteins in human cells or genetic knockout in mice (Babst et al., 2000; Bache et al., 2003 Bache et al., , 2004 Bishop et al., 2002) . Since the Ub ligation and binding proteins used in this process are shared by many related pathways, knockdown strategies that eliminate these components would also be expected to produce multiple direct and indirect effects. Similarly, it cannot be ruled out that the effects seen with Cbl mutants on endocytosis result from deficient ubiquitination of proteins besides EGFR Thien et al., 2001 ). As such, direct identification of the ubiquitination sites on EGFR is necessary, since specific mutation of these residues provides an opportunity to isolate and directly test the functional significance of EGFR ubiquitination in receptor internalization and trafficking.
In the current study, we have used tandem mass spectrometry (LC-MS/MS) to identify specific lysine residues within EGFR that are modified by Ub. Using the Ub-AQUA technique, it was further possible to examine the forms of Ub bound to the substrate. Surprisingly, we found that EGFR is markedly polyubiquitinated, with poly-Ub chains linked primarily through Lys63 of Ub. Based upon data from LC-MS/MS analysis, it was possible to develop a series of EGFR mutants that were deficient in growth-factor-stimulated ubiquitination. In these mutants, Ub-mediated receptor internalization was uncoupled from lysosomal degradation, revealing distinct Ub-dependent mechanisms for these two processes.
Results and Discussion
Ubiquitin Conjugation Sites Are Located in the Kinase Domain of EGFR To identify ubiquitination sites on the EGFR, large amounts of receptors were purified from porcine aortic endothelial (PAE) cells stably expressing wild-type (wt) human EGFR. Cells were untreated or treated with EGF for 2 min at 37ºC to stimulate maximum EGFR ubiquitination. EGFR was immunoprecipitated using an antibody to the extracellular domain of the receptor and stringently washed to minimize coprecipitation of other proteins. Immunopurified EGFR was separated by SDS-PAGE and visualized by Coomassie blue or silver staining ( Figure 1A ). In order to analyze ubiquitinated EGFR by mass spectrometry, the gel region containing Ub-modified protein was excised, digested with trypsin, and analyzed by LC-MS/MS using a hybrid-linear ion trap Fourier transform mass spectrometer. This instrument made it possible to collect a high accuracy precursor ion measurement (<10 ppm) and an MS/MS spectra for each peptide ion. Database searching of these MS/ MS spectra revealed that EGFR was the predominant protein identified in these samples.
Numerous reports have demonstrated that trypsin digestion of a ubiquitinated protein produces unique 2GG signature peptides, which can be analyzed by standard LC-MS/MS techniques and used to identify substrate ubiquitination sites (Kirkpatrick et al., 2005) . These signature peptides can be identified in database searches by modifying search parameters to allow for an additional mass of 114.0429 Da (corresponding to the 2GG Ub remnant) on lysine residues. Using this approach, we identified six distinct ubiquitination sites on EGFR. MS/MS spectra obtained during this analysis matched 2GG signature peptides corresponding to ubiquitination of EGFR at lysines 2692, 2713, 2730, 2843, 2905, and 2946 ( Figure 1B , see Figure S1 in the Supplemental Data available with this article online). Representative spectra are shown that demonstrate ubiquitination at lysine 843 ( Figure 1C ) and lysine 905 ( Figure 1D ). In the case of the six 2GG signature peptides identified, the mass deviation between the observed and expected precursor ions was found to be between 2 and 10 ppm. In each case, manual validation independently confirmed the ubiquitination site assignment.
Sequence analysis revealed that each of the ubiquitination sites identified map to the kinase domain of EGFR. Using a previously reported structure of the EGFR kinase domain (Stamos et al., 2002) , we found that these six lysines are distributed throughout the surface of the domain (Figure 2A ). Although Western blotting revealed that the total amount of Ub conjugated to the stably expressed Y1045F mutant EGFR was approximately an order of magnitude lower than in wt EGFR ( Figure 1A ), LC-MS/MS analysis revealed that at least two of these sites, Lys713 and Lys843, could still be ubiquitinated in the Y1045R mutant. In contrast, no 2GG signature peptides were identified in samples containing unstimulated wt EGFR.
To investigate the effects of EGFR ubiquitination on receptor function, lysine residues corresponding to specific EGFR ubiquitination sites were mutated to arginines. Single and multiple site-point mutants (nKR) of five, six, or nine lysines ( Figure 2B ) were generated and transiently expressed in PAE cells. In the 9KR mutant, besides the six lysines found to be modified by Ub, three additional lysines (Lys689, Lys690, and Lys733) situated in close proximity to confirmed ubiquitination sites were also substituted with arginines (Figure 2B) . Western blot analysis revealed that single mutations of all individual sites and various combinations of two or three mutations did not result in a significant decrease in the ubiquitination of EGFR (data not shown). However, ubiquitination of 5KR, 6KR, and 9KR mutants was reduced by w70%-80% as compared to wtEGFR ( Figure 2B ). Similarly, cells stably expressing 5KR or Y1045F mutant forms of the receptor displayed weak ubiquitination (about 20% compared to wtEGFR) ( Figure 2C ). In all of the mutants, residual ubiquitination was observed following EGF stimulation.
Despite multiple Lys/Arg mutations within the kinase domain, the extent of tyrosine phosphorylation for KR mutants was essentially similar to that of wt receptors ( Figures 2B and 2C ). All nKR mutants stably expressed in PAE cells were capable of activating MAPK/ ERK1/2, its upstream kinase (MEK1/2), and Akt kinase to a comparable extent as in cells expressing wt EGFR (data not shown, see also Figure 5 below). These data suggest that multiple lysine-to-arginine substitutions within the kinase domain had a direct effect on ubiquitination but did not affect the tyrosine kinase activity of EGFR or its signaling capacity.
EGFR Is Polyubiquitinated
It has been previously reported that EGFR ubiquitination occurs exclusively in the form of mono-Ub (Haglund et al., 2003; Mosesson et al., 2003) . As a part of LC-MS/MS analysis of ubiquitinated EGFR samples, we observed a series of peptides corresponding to K48-, K63-, and K11-linked poly-Ub chains. To quantify the various forms of Ub bound to EGFR, samples were analyzed using the newly developed Ub-AQUA method (D.K. and S.G., unpublished data). This method utilizes a series of isotope-labeled internal standard peptides and selected reaction monitoring (SRM) experiments to quantify each poly-Ub chain linkage as well as mono-Ub.
Analysis of samples from unstimulated cells revealed a low background level of Ub. Following EGF stimulation, 2.91 pmol total Ub was measured in the gel region immediately above EGFR (>170 kDa), equating to an increase of more than 20-fold over unstimulated receptor (Figures 3A and 3B) . Contrary to published reports, more than half of all EGFR-associated Ub was found not as mono-Ub but rather in the form of poly-Ub chains. Poly-Ub chains linked through K63 were more abundant than all other linkages combined, making up 41.8% of the total Ub. In addition to 1.22 pmol K63 branched peptide, 0.20 pmol K48, 0.12 pmol K11, and 0.03 pmol K29 chains were also detected ( Figure 3B ).
Because of weak ubiquitination of 5KR and Y1045F mutants, Ub-AQUA analysis required higher amounts of starting material than corresponding analysis of wt EGFR. Despite less efficient overall ubiquitination, the linkage profile for Ub bound to mutant forms of EGFR was strikingly similar to what was seen in wt EGFR ( Figure 3C ).
The detection of EGFR polyubiquitination was surprising in light of published data showing that EGFR is exclusively monoubiquitinated (Haglund et al., 2003; Mosesson et al., 2003) . It is difficult to reconcile our results with the latter reports, which based their conclusions on the inability of FK1/2 antibodies to recognize both mono-Ub and ubiquitinated EGFR and on the use of Ub mutants deficient in polyubiquitination. This result may indicate that FK1/2 antibodies do not efficiently recognize K63-linked Ub chains. Alternatively, since transfection of mutant Ub does not eliminate the abundant pools of endogenous Ub, it is likely that mutant Ub acts as an endcap on polyubiquitin chains formed with endogenous Ub. Regardless of the nature of the discrepancy, mass spectrometry analysis of immunopurified EGFR unequivocally demonstrated K63-linked polyubiquitination of EGFR that was proportionally reduced in two distinct EGFR mutants ( Figures 2C and  3C ). K63-linked polyubiquitin chains are proposed to function in DNA repair, IkB kinase activation, translational regulation, and endocytosis in yeast, although their mechanistic role in these processes is still unclear (Deng et al., 2000; Galan and Haguenauer-Tsapis, 1997; Hofmann and Pickart, 1999; Spence et al., 2000) . Thus, predominant K63 polyubiquitination is consistent with the nonproteosomal function of EGFR ubiquitination.
Ubiquitination Sites Are Essential for EGFR Degradation EGFR ubiquitination has been implicated in the regulation of EGFR trafficking. To directly test this hypothesis, wt and nKR mutant forms of EGFR were transiently expressed in PAE cells and used to measure growthfactor-stimulated EGFR turnover rates. Treatment of cells with EGF led to degradation of wt EGFR with a half-life of 1.5-2.0 hr ( Figures 4A and 4B ). In contrast, the levels of 5KR, 6KR, and 9KR forms of the receptor remained virtually unchanged after 4 hr incubation of cells with EGF. Similarly, EGF-induced degradation of the 5KR mutant receptor was much slower than that of the wt receptor in two separate stable cell lines ( Figures  4C and 4D) . Moreover, measurements of the number of 125 I-EGF binding sites at the cell surface upon EGF treatment revealed a very low rate of downregulation of 5KR mutant ( Figure 4E ).
Increased stability of mutant EGFRs in cells stimulated with EGF suggests that signaling by these EGFR mutants can be prolonged. The time course of EGFR activation (phosphorylation of the one of the major EGFR sites, Tyr1086) and MEK1/2 was comparable in cells expressing wt and 5KR receptors ( Figure 5A ). Probing EGFR with antibodies to pTyr1068 and pTyr1148 produced essentially similar results (data not shown). Significant differences in the stability of activated EGFR were observed only in the presence of EGF concentrations that cause downregulation of the total EGFR protein (R20 ng/ml). Under these conditions, the amount of active wt EGFR dramatically decreased after 2 hr incubation with EGF, whereas the level of activity of 5KR mutants remained unchanged ( Figure 5B ). However, despite different stability of activated wt and mutant receptors, the extent of MEK1/2 activation by both receptors was similar ( Figure 5B ). Interestingly, after comparable initial activation (5 min of EGF stimulation), the amount of activated 5KR receptors decayed more slowly than that for wt EGFR ( Figure 5C ). Dephosphorylation of MEK1/2 after removal of EGF from the medium was followed by a new ''late'' wave of MEK1/2 activation. The amplitude of late MEK1/2 activation was higher in cells expressing 5KR mutant than in wt EGFR-expressing cells. It is possible that an elevated, late MEK1/2 activity is due to slow degradation and increased recycling of activated 5KR receptors. Nevertheless, the data in Besides the six sites identified by LC-MS/MS, three structurally adjacent lysines (K689/K690/K733) from the kinase domain were also mutated (9KR). Wt and mutant receptors were transiently expressed in PAE cells, and EGFR immunoprecipitates were probed with Ub, phosphotyrosine, and EGFR antibodies. The mean amount of Ub and phosphotyrosine normalized to total EGFR (6SD) from four experiments is presented on the graphs. (C) EGFR was immunoprecipitated from PAE cells stably expressing wtEGFR (clone B2), 5KR (clone #1), and Y1045F mutants (clone #1), and the extent of ubiquitination and phosphorylation was determined in three experiments as in (B). The mean amount of Ub and phosphotyrosine normalized to total EGFR (6SD) from four experiments is presented on the graphs. signaling in PAE cells. Presumably, the extent of MAPK activation is limited by saturable factors and processes downstream of EGFR.
The inhibition of EGF-induced degradation of nKR mutants observed in Figures 4 and 5 could be due to slow internalization or impaired lysosomal degradation of EGF-receptor complexes. Our previous results have suggested that transient transfection leads to overexpression of the receptor in the majority of cells so that the pathway responsible for rapid internalization becomes saturated (Carter and Sorkin, 1998) . Likewise, internalization of 125 I-EGF in cells transiently expressing wt or nKR mutant EGFRs was similarly slow as compared with the maximum high rates measured for clathrin-dependent EGFR internalization in PAE cells ( Figure 6A) . As in the case of transient transfections, treatment of cells stably expressing EGFR with saturating EGF concentrations results in receptor internalization primarily through a slow, clathrin-independent pathway. No difference was observed between the receptor internalization rate for wt versus mutant-expressing cell lines under these conditions ( Figure 6A ). Therefore, the defect in the turnover of nKR mutants is likely due to the blockade of lysosomal targeting rather than the internalization step of EGFR trafficking.
To further explore the nature of the delayed downregulation of ubiquitination-deficient receptor mutants, the localization of EGF-occupied 5KR mutant was analyzed. After 10 min of cell stimulation with EGF conjugated with rhodamine (EGF-Rh) or fluorescein (EGF-FC), both wt EGFR and 5KR mutant were well colocalized with the marker of early endosomes, EEA.1 ( Figures  7A and 7B) . At the same time, very little, if any, localization of both receptors in late endosomes and lysosomes, marked by LysoTrackerRed, was observed ( Figures 7C and 7D) . After 3 hr of continuous incubation of cells expressing wt EGFR with labeled EGF, about 70% of EGF-FC was accumulated in late endosomes/ lysosomes ( Figures 7C and 7D ) while very little, if any, EGF-Rh could be detected in early endosomes ( Figures  7A and 7B) . In contrast, a significant pool of 5KR mutant remained in EEA.1-positive compartments ( Figures 7A  and 7B ), and only a small amount of the mutant receptor reached late endosomes/lysosomes ( Figures 7C and  7D) . Together with the poor downregulation of the surface 5KR mutant ( Figure 4E ), the data in Figure 7 suggest that 5KR mutant is not efficiently sorted to the late endosome/lysosome pathway and instead accumulated in early endosomal compartments where it is extensively recycled to the plasma membrane.
The establishment of the role of EGFR ubiquitination in the lysosomal targeting and degradation of the receptor and the detection of marked EGFR K63 polyubiquitination raise the question of what role Ub chains play in EGFR trafficking. Structural studies of K63-linked diubiqutin have revealed that each of the two ubiquitins can bind the Ub binding domain in the same mode as does monoubiquitin (Varadan et al., 2004) . It can, therefore, be suggested that K63 chains allow for multivalent interactions of the receptor with Ub binding proteins in endosomes, such as Hrs and TSG101, which may be necessary to allow an efficient sorting of the ubiquitinated receptors to internal vesicles of MVBs. A recent study using mutant Ub lacking Lys63 has proposed that polyubiquitination through this residue can mediate endocytosis of TrkA RTK (Geetha et al., 2005) . Although an E3 (E) Cells stably expressing wt or 5KR mutant (clone #1) were incubated with EGF as in (A) for indicated times. The cells were then acid washed to remove unlabeled EGF from surface receptors, and the number of surface EGF binding sites was measured using incubation with 125 I-EGF (50 ng/ml) at 4ºC for 1 hr. Each data point represents a value averaged from three experiments (6SD).
ligase and other regulators of TrkA ubiquitination are different than those controlling EGFR ubiquitination, the hypothesis can be put forward that K63-linked Ub chains could be a common signal in RTK trafficking.
Major Ubiquitination Sites Are Not Essential for EGFR Internalization
To compare rates of internalization of wt and mutant EGFR through the clathrin-dependent pathway, cell (A) PAE cells stably expressing wtEGFR or 5KR (clone #1) were serum starved, treated with 10 ng/ml EGF for indicated times at 37ºC, and lysed in the presence of OV and NEM. The cell lysates were probed for active EGFR (antibody pY1086), total EGFR (Ab2913), phosphorylated MEK1/2, and total MEK. The experiment is representative of three independent experiments. (B) Serum-starved cells were treated with 1 ng/ml (w0.8 3 10 6 cells/lane) or 5, 10, or 20 ng/ml (w0.25 3 10 6 cells/lane) for 0, 10, or 120 min at 37ºC. Active EGFR and MEK1/2 were detected as in (A). All steps of the experiment were performed identically for wt EGFR and mutant-expressing cells. The experiment is representative of three independent experiments. EGF-induced downregulation of EGFR was accompanied by the appearance of a low molecular mass EGFR form (w160 kDa), a product of partial proteolysis of EGFR that is not detected by antibodies to active EGFR (A and B). Note that Ab2913 recognized the EGF-activated full-length EGFR (w175 kDa) with a lesser efficiency than the truncated EGFR species. (C) Serum-starved cells were treated with 10 ng/ml EGF for 5 min at 37ºC, washed, and further incubated for indicated times (Chase Time) without EGF. Active EGFR and MEK1/2 were detected in cell lysates as in (A). The mean amounts of active EGFR and MEK1/2 normalized to total EGFR and MEK1/2, respectively, from three experiments (6SD) plotted against chase time are presented on the graphs at the right. lines stably expressing these mutants were used. In these cell lines, it is possible to measure the rates of EGFR internalization via rapid, physiological pathway of endocytosis by using low concentrations of EGF. Because of different expression levels of receptors in various cell lines, the pathway of clathrin-mediated endocytosis can be saturated at different occupancies of surface EGFR. Therefore, 125 I-EGF internalization rates of wt and mutant EGFR were measured using a range of EGF concentrations to compare maximum high internalization rates. Figure 6A shows that, although there was significant variation in the maximal rates of internalization, all nKR cell lines internalized 125 I-EGF within the range of the internalization rates of EGFR reported in various types of cells (>0.2/min) Huang et al., 2004; Wiley, 1988) .
125 I-EGF internalization rate constants in nKR-expressing cells were also comparable with these constants measured for the transferrin receptor, a cargo that is constitutively internalized via clathrin coated pits (Huang et al., 2004) . These data suggested that complete EGFR ubiquitination is not essential for clathrin-dependent internalization of EGFR.
Internalization of Lysine Mutants of the EGFR Is Mediated by Grb2 and Cbl
If internalization of nKR mutant EGFR does not require efficient ubiquitination, is it regulated by the same mechanisms as the internalization of wt receptors? Using a combination of siRNA and dominant-negative overexpression approaches, we previously demonstrated that clathrin-dependent endocytosis requires Grb2 and its interaction with Cbl proteins in PAE and other cells (Huang and Sorkin, 2005; . Using this same Grb2 siRNA approach, we found that Grb2 is necessary for clathrindependent 125 I-EGF internalization by 5KR and 9KR receptors ( Figure 6B ).
To test for the importance of Cbl proteins in EGFR internalization, siRNA duplexes targeted to c-Cbl and Cbl-b were generated. When transfected together, these siRNAs caused significant depletion of both Cbl proteins and a substantial inhibition of 125 I-EGF internalization in cells expressing wt, 5KR, or 9KR mutant EGFR ( Figure 6B) . Together with the observation of essentially similar kinetics of internalization compared to wt EGFR, the RNA interference experiments suggested that 5KR Figure 7 . Trafficking of 5KR Mutant Is Delayed in Early Endosomes (A) Cells stably expressing wtEGFR and 5KR mutant were preincubated with leupeptine and incubated with EGF-Rh (100 ng/ml) for 10 min or 3 hr. After fixation, the cells were stained with antibody to EEA.1. A Z stack of images was acquired through Cy3 (EGF-Rh) and FITC (EEA.1) filter channels and deconvoluted. Optical sections through the middle of the cell are shown. Arrows indicate examples of colocalization of EGF-Rh and EEA.1. Scale bars, 10 mm. (B) The relative amount of EGF-Rh in EEA.1-containing endosomes was calculated from two experiments performed as in (A). Each data point represents value averaged from ten cells (6SD). (C) Cells were preincubated with leupeptine and then incubated with EGF-FC (100 ng/ml) as in (A). The cells were incubated with LysoTracker for 30 min at 37ºC so that the end of the incubation was at the time of end of incubation with EGF-FC and beginning of fixation. After fixation, a Z stack of images was acquired through Cy3 (LysoTrackerRed) and FITC (EGF-FC) filter channels and deconvoluted. Optical sections through the middle of the tail are shown. Arrows indicated on the examples of colocalization of EGF-FC and LysoTracker. Scale bars, 10 mm. (D) The relative amount of EGF-FC in vesicles containing LysoTrackerRed was calculated from two experiments performed as in (C). Each data point represents value averaged from ten cells (6SD). and 9KR mutant receptors are internalized using the mechanisms normally operating during rapid internalization of the wt EGFR. These experiments also directly demonstrated that Cbl is required for clathrin-dependent EGFR internalization. The data obtained using siRNA Cbl depletion are consistent with the previous reports of dominant-negative effects of Cbl mutants on EGF internalization and the ability of Cbl-Grb2 chimera to rescue EGFR endocytosis in Grb2-depleted cells (Huang and Sorkin, 2005) . However, the same data are inconsistent with the observation of normal endocytosis in mouse embryonic fibroblasts with targeted knockout of c-Cbl (Duan et al., 2003) . One possible explanation for this discrepancy is the presence of Cbl-b in c-Cbl knockout cells. In fact, in several types of cells, only highly efficient knockdown of both c-Cbl and Cbl-b allowed the demonstration of Cbl requirement for EGFR internalization (data not shown).
We and others have previously demonstrated that the intact Cbl RING domain is necessary for EGFR internalization (Huang and Sorkin, 2005; Thien et al., 2001) . To confirm that this domain is also required for internalization of ubiquitination-deficient EGFR mutants, a naturally occurring c-Cbl mutant lacking RING domain activity, 70Z-Cbl, was overexpressed to examine its effects on EGFR internalization. Because the efficiency of transient transfection of PAE cells is not sufficient for biochemical endocytosis assays, singlecell internalization assays were performed using EGF-Rh. As shown in Figure 6C , accumulation of EGFRh in peripheral and perinuclear endosomes of PAE/ 5KR cells was not affected by overexpression of wt c-Cbl. However, endocytosis was impaired in PAE/ 5KR and PAE/9KR cells overexpressing 70Z-Cbl mutant, as revealed by very few endosomes containing EGF-Rh ( Figure 6C and Figure S2 ) and significant reduction of the total amount of EGF-Rh in the cells ( Figure 6D ). As in our previous studies using PAE cells expressing wtEGFR , EGF-Rh in PAE/5KR cells overexpressing 70Z-Cbl was localized in small dots, previously identified as clathrin-coated pits, and also diffusely distributed throughout the plasma membrane (see insets in Figure 6C and Figure S2 ). Thus, despite its ubiquitination defect, internalization of the 5KR and 9KR mutants still required an intact RING domain of Cbl.
Two models can be proposed to explain the requirement of Cbl and its RING domain but not efficient EGFR ubiquitination in this process. One possibility is that Cbl RING domain is necessary to recruit proteins besides EGFR to the pit. In this model, recruitment of EGFR-associated proteins may or may not be Ub dependent (requiring the RING activity). In fact, it has been proposed that ubiquitination of a component of endocytosis apparatus is required for endocytosis of a factor receptor in yeast (Dunn and Hicke, 2001 ) and growth hormone receptor in mammalian cells (Govers et al., 1999) . While the participation of other ubiquitination targets of Cbl may be the case, we believe that our results point toward a multiple threshold model in which each step in the internalization and trafficking of EGFR requires more extensive ubiquitination. In this case, residual ubiquitination of the receptor in the absence of major ubiquitination sites, as was seen here, would be predicted to be sufficient for receptor internalization but not further postendocytic trafficking. This model assumes that the strength of the interaction of weakly ubiquitinated EGFR with Ub binding proteins in clathrincoated pits is higher than in endosomes, since the same residual ubiquitination is not sufficient for EGFR trafficking to MVBs or its lysosomal degradation. Thus, we propose that the density of Ub modifications on EGFR sets regulatory thresholds allowing internalization and endosomal sorting steps of EGFR trafficking to be uncoupled.
Experimental Procedures
Reagents EGF-Rh, EGF-FC, and LysoTrackerRed were purchased from Molecular Probes (Eugene, Oregon). Monoclonal antibodies to c-Cbl, phosphotyrosine (PY20), and EEA.1 were from BD Transduction Laboratories (San Diego, California) and monoclonal antibody to EGFR (Ab528) from American Type Culture Collection (Manassas, Virginia). Monoclonal antibody to Ub (P4D1) and polyclonal antibody to Cbl-b were from Santa Cruz Biotechnology (Santa Cruz, California). Polyclonal antibody to phosphorylated MEK1/2, monoclonal antibody to total MEK1/2, and polyclonal antibody to EGFR phosphotyrosine 1086 (pY1086) were from Cell Signaling Technology (Beverly, Massachustts). Rabbit serum Ab2913 to the intracellular domain of EGFR was kindly provided by Dr. L. Beguinot (DIBIT Rafaele, Milan, Italy) and polyclonal antibody to actin was from Sigma (St. Louis, Missouri).
Plasmids and Mutations
The c-Cbl-YFP (wt and 70Z) and EGFR (wt and Y1045F mutant) constructs were described previously . Point mutations were generated using the QuikChange Site-Directed Mutagenesis Kit according to the manufacture protocol (Stratagene Cloning Systems, La Jolla, California). All point mutations were verified by automated dideoxynucleotide sequencing.
Cell Culture and Transfections PAE cells were grown and transiently DNA transfected as described . Transfected cells were split 1 day after transfection and used for experiments on the second day. PAE cell lines stably expressing various mutated EGFRs were generated as previously described .
In siRNA knockdown experiments, Grb2 siRNA duplex or c-Cbl (967-985, target sequence 5 0 -CCTCTCTTCC AAGCACTGA-3 0 ) and Cbl-b (414-432, target sequence 5 0 -GGACAG ACGAAATCTCACA-3 0 ) siRNA duplexes together were resuspended in 13 siRNA universal buffer (Dharmacon, Inc., Lafayette, Colorado) to 20 mM prior to transfection. PAE/EGFR cell lines grown in 6-well plates (50%-60% confluency) were transfected with 10 ml Grb2 siRNA3 duplex or a mixture of 5 ml c-Cbl siRNA and 5 ml Cbl-b siRNA duplexes in 5 ml DharmaFECT I reagent (Dharmacon) for 3 days. For mock transfections, control cyclophilin siRNA (Dharmacon) was used. Cells were replated to 12-well dishes 24 hr prior to experiments.
LC-MS/MS Analysis of EGFR Ubiquitination
For mass spectrometry analysis, PAE cells stably expressing wt or mutant EGFR were grown in 150 mm dishes. Cells were untreated or treated with 20 ng/ml EGF, washed with Ca 2+ , Mg 2+ -free phosphate buffered saline (CMF-PBS), and lysed in Triton X-100/glycerol/HEPES solubilization buffer (TGH) (Huang et al., 2004) containing 1% sodium deoxycholate and 10 mM N-ethyl-maleimide (NEM). Lysates were cleared by centrifugation (10 min, 14,000 3 g). EGFR was immunoprecipitated with antibody Ab528. The precipitates were washed three times with TGH/DOC containing, sequentially, 500 mM, 100 mM, and no NaCl and resolved by SDS-PAGE.
Gel regions containing Ub-EGFR were excised, destained, and digested using 15 ng/ml trypsin. Following extraction, digested peptides were analyzed on an LTQ-FT hybrid linear ion trap Fourier transform mass spectrometer equipped with a Famos Autosampler (LC Packings, San Francisco, California) and an Agilent 1100 Series HPLC pump (Agilent Technologies, Palo Alto, California). Peptides were first loaded onto fused silica microcapillary column packed with reversed phase C18 material (Magic C18AQ, Michrom Bioresources, Auburn, California). Peptides were eluted using a linear gradient of 5%-40% buffer B (97.5% acetonitrile/0.15% formic acid) in buffer A (2.5% acetonitrile/0.15% formic acid). The LTQ-FT was operated in data-dependent top ten mode as has been described (Haas et al., 2006) . To obtain maximum sensitivity, automatic gain control (AGC) settings of 3 3 10 6 for MS (in the FT-MS) and 2 3 10 4 for MS/MS (in the linear ion trap-MS) were employed. Protein identifications were made by database searching an indexed version of the nonredundant database available from NCBI. To identify EGFR ubiquitination sites, searches were modified to allow for lysine modification with a mass of 114.0429 Da in a simplified form of the human database containing protein sequences for EGFR, ubiquitin, and known contaminants.
Immunoprecipitations and Western Blotting
To examine ubiquitination and tyrosine phosphorylation of EGFR by Western blotting, PAE cells stably expressing EGFR or transiently transfected with EGFR constructs in 60 mm dishes for 2 days were pretreated with 20 ng/ml EGF for 2 min at 37ºC and washed with CMF-PBS. The cells were lysed in TGH/NEM, and EGFR was immunoprecipitated as described above. In experiments examining EGFR degradation, the cells stably or transiently expressing EGFR were serum starved overnight and incubated with EGF (100 ng/ml) for indicated times. The cells were lysed in TGH as above, with the exception that orthovanadate (OV) and NEM were omitted from the lysis buffer. This was necessary to provide equal efficiency of Western blot detection of inactive and activated EGFR by Ab2319.
To probe for active EGFR and MEK1/2, cells in 12-or 6-well plates were serum starved overnight, treated with EGF at 37ºC for indicated times, and lysed in TGH buffer containing 1 mM sodium OV and 10 mM NEM.
Western blotting of cell lysates and EGFR immunoprecipitates was performed as described (Huang et al., 2004) . Several X-ray films were analyzed to determine the linear range of the chemiluminescence signals, and the quantifications were performed using densitometry.
I-EGF Internalization
Mouse receptor-grade EGF (Collaborative Research Inc., Bedford, Massachusetts) was iodinated as described previously .
125 I-EGF internalization was measured using 0.5-40 ng/ml 125 I-EGF, and the specific rate constant for internalization k e was calculated as described previously .
EGFR Downregulation
The number of surface EGFR before and after EGF treatment was measured using 125 I-EGF binding assay as previously described (Carter and Sorkin, 1998) .
Fluorescence Microscopy PAE/EGFR cells grown on glass coverslips were transiently transfected with Cbl-YFP. The cells were treated with 2 ng/ml EGF-Rh at 37ºC for 5 min, washed with ice-cold phosphate buffer saline, and fixed with freshly prepared 4% paraformaldehyde (Electron Microscopy Sciences, Ft. Washington, Pennsylvania). A Z stack of images was acquired and deconvoluted using a Marianas imaging workstation and SlideBook 4.1 software (Intelligent Imaging Innovation, Inc, Denver, Colorado) as described previously (Huang and Sorkin, 2005) . The amount of EGF-Rh in individual cells that do not express or express Cbl constructs was calculated as described (Huang and Sorkin, 2005) .
To determine the extent of colocalization of EGFR with EEA.1, the cells were preincubated with leupeptine (21 mM) for 1 hr at 37ºC to block lysosomal degradation and then incubated with 100 ng/ml EGF-Rh in the same medium at 37ºC for indicated times. The cells were then fixed as above and stained with EEA.1 antibody followed by secondary antibody conjugated with fluorescein, all incubations in the presence of 0.02% saponin. To determine the extent of colocalization of EGFR and LysoTrackerRed, the experiments were performed as above, with the exception that EGF-FC was used instead of EGF-Rh, and the cells were fixed and imaged without permeabilization. The cells were incubated with LysoTracker (50 nM) for 30 min at 37ºC. The experiments were designed so that the 30 min incubation ended at the end of cell incubation with EGF-FC. In both types of experiments, a Z stack of two-dimensional images was acquired through FITC and Cy3 filter channels and deconvoluted using constrained iterative algorithm. The method of quantification of the relative amount of EGF-Rh or EGF-FC colocalized with EEA.1 or LysoTrackerRed, respectively, is described in Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and two figures and can be found with this article online at http:// www.molecule.org/cgi/content/full/21/6/737/DC1/.
